Browse studies

Find your next paid study

27,333 recruiting studies available now

Exploratory, Prospective, Single-Arm, Open-labeled Study of [Ga68]MTP220 PET for First-in-Human Biodistribution and Efficacy in Patients With Pancreatic Cancer and Head and Neck Cancers

The goal of this research study is to develop a diagnostic tool to help with detection and diagnosis of head and neck cancer (HNC) and pancreatic cancer (PaC).…

Head and Neck CancerPancreatic CancerCancer Pancreas

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Qiubai LiNCT07026981

Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

The goal of this clinical trial is to investigate the effects of early initiation of double low-dose aspirin in pregnant women. The main questions it aims to a…

Pre-EclampsiaPregnancy Loss

Estimated

~$50 – $1,500

Actual pay is set by the research site.

University of PennsylvaniaNCT06408181

Observational

A Randomized Controlled Trial Comparing Comprehensive Peripheral Deep Margin Assessment Versus Standard Breadloafing in Wide Local Excision Specimens of Clinical Stage I-II Cutaneous Melanoma

The primary goal of this clinical trial is to is to compare the rate of positive peripheral margins in wide local excision (WLE) performed to allow for compreh…

Cutaneous Melanoma, Stage IICutaneous MelanomaAcral Melanoma

Estimated

~$10 – $750

Actual pay is set by the research site.

University of NebraskaNCT07869381

Phase 1

A Phase I Multicohort Trial of Zamtocabtagene Autoleucel (Zamto-Cel) in Subjects With Severe Refractory Autoimmune Diseases

AID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune disea…

Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Miltenyi Biomedicine GmbHNCT06708845

Complementary and Alternative Medicine (CAM) in Multiple Sclerosis. A Prospective Observational Study of a CAM-using Cohort

This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency …

Multiple Sclerosis

Estimated

~$10 – $750

Actual pay is set by the research site.

Bastyr UniversityNCT01703429

Center for Inherited Muscle Research Neuromuscular Research Biobank

The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular diseas…

Neuromuscular DiseasesNeuromuscular DisorderNeuromuscular Diseases in Children

Estimated

~$10 – $750

Actual pay is set by the research site.

Virginia Commonwealth UniversityNCT05434572

Phase 4

Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial

The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo…

Leiomyoma, UterineLeiomyomaFibroid+1 more

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT06143631

Phase 1

Phase 1 Study to Determine the Safety and Efficacy of Onvansertib, A Novel, Oral, PLK1 Inhibitor in Patients With Proliferative Chronic Myelomonocytic Leukemia (CMML) and Myelodysplastic Syndrome/MPN Overlap Neoplasms Relapsed/Refractory or Intolerant to Available Therapies

This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia and Mye…

Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Participants With Neovascular Age-Related Macular Degeneration

This is a prospective study designed to evaluate the long-term safety and efficacy of ABBV-RGX-314. Eligible participants are those who were previously enrolle…

Neovascular Age-Related Macular Degeneration (nAMD)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT05210803

Phase 2

Early Concomitant Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

The goal of this clinical trial is to compare the effectiveness and safety of Vedolizumab with a short course of steroids compared to standard course of steroi…

Immune Checkpoint Inhibitor-Related Colitis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Shilpa Grover, MD, MPHNCT06841705

A Prospective, Observational, Multi-center Study to Gather Real World Use Data on the Effectiveness, Safety, and Site-of-service of the Cerene Device

Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress regist…

Heavy Menstrual BleedingAbnormal Uterine BleedingMenorrhagia

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Channel MedsystemsNCT05922657

Phase 4

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

The investigators aim to address the following specific aims: * Determine the efficacy of Prog in preventing postpartum smoking relapse and reducing smoking r…

SmokingSmoking CessationSmoking Reduction

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of MinnesotaNCT04783857